proprietary drug

A second proprietary drug, the migraine treatment fremanezumab, is expected to hit the U.S. market by the end of the year, after suffering delays due to manufacturing problems, and be introduced in Europe next year.

Their ability to get good-faith, unbiased medical advice, as opposed to medical advice that is always selling you to the nearest proprietary drug and that sort of thing, that is worrying.

This costs you and me an estimated $3.5 billion a year – a hidden upward redistribution of our incomes to Pfizer, Merck, and other big proprietary drug companies, their executives, and major shareholders.

In total, Israel has nearly 1,000 life science firms, of which about 29 percent are in biopharma, developing proprietary drugs and experimenting with stem cells to treat diseases such as diabetes, Gaucher and leukemia.

The researchers said they are working on a test to determine which patients might require the proprietary drugs.